Bromide

Bromide

SCHEMBL368453

C=CC[N+](CC=C)(CC=C)CC=C.C=CC[N+](CC=C)(CC=C)CC=C.C=CC[N+](CC=C)(CC=C)CC=C.[Br-].[Br-].[Br-]

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.30
TSHR P16473 2/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL463372 1.00 TSHR (0.31) TSHRALDH1A1ACHE
Bromide SCHEMBL368454 0.96
Hydrogen Sulfide SCHEMBL28090943 0.96 TSHR (0.33) TSHRALDH1A1
SCHEMBL197824 0.96 TSHR (0.33) TSHRALDH1A1
Bromide SCHEMBL28874797 0.93
SCHEMBL596385 0.92 TSHR (0.31) TSHRALDH1A1
Hydrochloric Acid SCHEMBL20896 0.92 TSHR (0.31) TSHRALDH1A1
Iodide SCHEMBL2796494 0.92 TSHR (0.31) TSHRALDH1A1
Fluoride Ion SCHEMBL1260645 0.92 TSHR (0.31) TSHRALDH1A1
Fluoride Ion SCHEMBL33106 0.92 TSHR (0.31) TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174687-A1 PROCESS FOR THE PREPARATION OF BROMINATED COPOLYMERS OF CONJUGATED DIENES AND STYRENIC MONOMERS LANXESS CORPORATION (US) 2023-06-08 US claimed
CN-104177516-A Bromized aliphatic olefin/vinyl aromatic copolymer flame retardant and preparation method thereof QINGDAO FUNDCHEM CO LTD 2014-12-03 CN claimed
US-8779066-B2 Process for brominating butadiene polymers using ester solvent mixtures DOW GLOBAL TECHNOLOGIES LLC (US) 2014-07-15 US claimed
US-20140121330-A1 PROCESS FOR BROMINATING BUTADIENE POLYMERS USING ESTER SOLVENT MIXTURES THE DOW CHEMICAL COMPANY 2014-05-01 US claimed
CN-102257016-B Process for brominating butadiene polymers using ester solvent mixtures DOW GLOBAL TECHNOLOGIES INC 2014-04-09 CN claimed
EP-2379605-B1 PROCESS FOR BROMINATING BUTADIENE POLYMERS USING ESTER SOLVENT MIXTURES DOW GLOBAL TECHNOLOGIES LLC (US) 2014-03-12 EP claimed
CN-101959901-B Process for brominating butadiene copolymers by the addition of water or certain solvents DOW GLOBAL TECHNOLOGIES LLC 2013-05-08 CN claimed
US-8410226-B2 Two-step process for brominating butadiene copolymers DOW GLOBAL TECHNOLOGIES LLC (US) 2013-04-02 US claimed
CN-102015774-B Two-step process for brominating butadiene copolymers DOW GLOBAL TECHNOLOGIES INC 2013-01-02 CN claimed
EP-2274338-B1 TWO-STEP PROCESS FOR BROMINATING BUTADIENE COPOLYMERS DOW GLOBAL TECHNOLOGIES LLC (US) 2012-12-12 EP claimed
WO-2009139942-A2 PROCESS FOR BROMINATING BUTADIENE COPOLYMERS BY THE ADDITION OF WATER OR CERTAIN SOLVENTS DOW GLOBAL TECHNOLOGIES INC. (US) 2009-11-19 WO claimed
CN-101583631-A Process for brominating butadiene/vinyl aromatic copolymers DOW GLOBAL TECHNOLOGIES INC (US) 2009-11-18 CN claimed
WO-2009134628-A1 TWO-STEP PROCESS FOR BROMINATING BUTADIENE COPOLYMERS DOW GLOBAL TECHNOLOGIES INC. (US) 2009-11-05 WO claimed
US-7605267-B2 Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones NOVARTIS AG (CH) 2009-10-20 US claimed
EP-2054445-A2 PROCESS FOR BROMINATING BUTADIENE/VINYL AROMATIC COPOLYMERS Dow Global Technologies Inc. (US) 2009-05-06 EP claimed
WO-2008021417-A2 PROCESS FOR BROMINATING BUTADIENE/VINYL AROMATIC COPOLYMERS DOW GLOBAL TECHNOLOGIES, INC. (US) 2008-02-21 WO claimed
JP-2006522055-A 2006-09-28 JP claimed
US-20060189653-A1 Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones NOVARTIS AG (CH) 2006-08-24 US claimed
EP-1613599-A1 A PROCESS FOR THE PREPARATION OF 5-(HALOACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLIN-2-ONES Novartis AG (CH) 2006-01-11 EP claimed
WO-2004087668-A1 A PROCESS FOR THE PREPARATION OF 5-(HALOACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLIN-2-ONES NOVARTIS AG (CH) 2004-10-14 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189653-A1 Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones UGT8, KAT8, UGT1A8 ACHE 1054/4885TSHR 1260/4885ALDH1A1 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.